Submitted by Anonymous (not verified) on 8 June 2026 - 16:04
Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 24, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 24, Status: Authorised